Skip to content
Álvaro Pinto· @dralvaropinto · X·· 2 days agoScore70

KN-866

Body · original

KN-866: perioperative CisGem +/- Pembro in MIBC. No benefit in EFS/OS, slight increase in pCR. Big difference compared with NIAGARA. Which could be the reasons that explain these discordant results? #ESMO26

89 views · 0 likes · 0 reposts · 0 replies

Source: Álvaro Pinto · x.com

CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org